Database: Croatian National Cancer Registry (Croatia): Difference between revisions
No edit summary |
No edit summary |
||
| Line 18: | Line 18: | ||
'''Number of Records:''' > 500,000 cancer incidence registries. | '''Number of Records:''' > 500,000 cancer incidence registries. | ||
'''Date range:''' [[dataStart::1959]] [[dataEnd::onwards] | '''Date range:''' [[dataStart::1959]] [[dataEnd::onwards]]. | ||
'''Cancer Areas of Interest:''' [[hasCancerAreasList::all cancers except non-melanoma skin cancer (C44)]], including carcinoma in situ and benign and borderline CNS tumors [https://www.hzjz.hr/wp-content/uploads/2017/01/Bilten-Incidencija-raka-u-Hrvatskoj-2020.-godine.pdf Click here to learn more]. | '''Cancer Areas of Interest:''' [[hasCancerAreasList::all cancers except non-melanoma skin cancer (C44)]], including carcinoma in situ and benign and borderline CNS tumors [https://www.hzjz.hr/wp-content/uploads/2017/01/Bilten-Incidencija-raka-u-Hrvatskoj-2020.-godine.pdf Click here to learn more]. | ||
Revision as of 21:15, 5 May 2024
Go back to Croatia page
Primary purpose: Register new cancer cases and provide data on incidence, prevalence, and survival in Croatia.
Sponsor, manager or home institution: Croatian Institute of Public Health.
Type of information: Data dictionary was not found.
Available type of information: cancer incidence (number of new cases, percentage, crude incidence rate, standardized world incidence rate, cumulative rate from 0 - 74 years), number of deaths, primary tumor localization, diagnosis, sex, age, year, place of residence. Click here to learn more.
Source of Information: Hospital report forms, primary care report forms, pathology and cytology reports, and death certificates. Additional data sources include hospital discharge diagnoses and outpatient visit diagnoses.
Data level: patient level.
Available data level: regional level.
Number of Records: > 500,000 cancer incidence registries.
Date range: 1959 onwards.
Cancer Areas of Interest: all cancers except non-melanoma skin cancer (C44), including carcinoma in situ and benign and borderline CNS tumors Click here to learn more.
Data access: partially publicly available. Click here to access. Instructions to request data for restricted content click here to access.
Contact information: Click here to access.